Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths

• Hauptverfasser: Peter A. Kropp (Verfasst von), Rosemary Bauer (Verfasst von), Isabella Zafra (Verfasst von), Carina Graham (Verfasst von), Andy Golden (Verfasst von)
• Format: Buch
• Veröffentlicht: The Company of Biologists, 2021-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Although nearly 10% of Americans suffer from a rare disease, clinical progress in individual rare diseases is severely compromised by lack of attention and research resources compared to common diseases. It is thus imperative to investigate these diseases at their most basic level to build a foundat...